|Number of samples:||22|
|Release date:||Feb 5 2013|
|Last update date:||Jan 23 2018|
|Chemicals:||Androgens, Dexamethasone, Mifepristone, Cyproterone Acetate|
|Dataset link||FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells (HTS)|
Examination of AR and GR binding sites in LNCaP-1F5 and VCaP cells in presence of DHT and Dex respectively. Further analysis of AR binding sites in LNCaP-1F5 cells treated with partial agonist/antagonists, CPA, RU486 and Bica. Additionally RNA Pol II mapping is performed in cells treated with DHT and Dex.
Olli A. Jänne